Quest Diagnostics 2000 Annual Report Download - page 45

Download and view the complete annual report

Please find page 45 of the 2000 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 108

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108

25
PART IV
Item 14. Exhibits, Financial Statement Schedules and Reports on Form 8-K
(a) Documents filed as part of this report:
1. Index to financial statements and supplementary data filed as part of this report:
Item Page
Report of Independent Accountants ................................................ F-1
Consolidated Balance Sheets........................................................... F-2
Consolidated Statements of Operations........................................... F-3
Consolidated Statements of Cash Flows.......................................... F-4
Consolidated Statements of Stockholders’ Equity........................... F-5
Notes to Consolidated Financial Statements ................................... F-6
Supplementary Data: Quarterly Operating Results (unaudited) ...... F-34
2. Financial Statement Schedule:
Item Page
Schedule II - Valuation Accounts and Reserves.............................. F-35
3. Exhibits filed as part of this report:
See (c) below.
(b) Reports on Form 8-K filed during the last quarter of 2000:
On October 31, 2000, the Company filed a current report on Form 8-K with respect to the acquisition of
SBCL.
(c) Exhibits filed as part of this report:
Exhibit
Number Description
2.1 Form of Transaction Agreement among Corning Incorporated, Corning Life Sciences Inc.,
Corning Clinical Laboratories Inc. (Delaware), Covance Inc. and Corning Clinical
Laboratories Inc. (Michigan), dated as of November 22, 1996 (filed as an exhibit to the
Company’s Registration Statement on Form 10 (File No. 1-12215) and incorporated
herein by reference)
3.1 Certificate of Incorporation of the Registrant (filed as an exhibit to the Company’s
Registration Statement on Form 10 (File No. 1-12215) and incorporated herein by
reference)
3.2 Amendment of the Certificate of Incorporation of the Registrant (filed as an Exhibit to the
Company’s proxy statement for the 2000 annual meeting of shareholders and incorporated
herein by reference)
3.3 Amended and Restated By-Laws of the Registrant
4.1 Form of Rights Agreement dated December 31, 1996 (the “Rights Agreement”) between
Corning Clinical Laboratories Inc. and Harris Trust and Savings Bank as Rights Agent
(filed as an Exhibit to the Company’s Registration Statement on Form 10 (File No. 1-